Comparison of alcoholism subtypes as moderators of the response to sertraline treatment.
- Authors
- Kranzler, Henry R; Feinn, Richard; Armeli, Stephen; Tennen, Howard
- Year
- 2012
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 21895712
- DOI
- 10.1111/j.1530-0277.2011.01609.x
- PMCID
- PMC3235238
BACKGROUND: A variety of typologies have been used to categorize alcoholism's diverse manifestations. Although the most widely studied typologies are dichotomous ones based on genetic epidemiologic findings or using cluster analytic methods, recent efforts have utilized a single item or the onset of a diagnosis of alcohol dependence to subtype individuals based on the age of alcoholism onset. We compared 3 different methods to subtype alcoholics. METHODS: This secondary analysis used data from 134 alcohol-dependent participants in a placebo-controlled trial of sertraline (Kranzler et al., 2011). We compared cluster analysis to distinguish 2 risk/severity subtypes (Babor et al., 1992) with 2 age-of-onset subtypes (i.e., based on the age of onset of problem drinking or the age at which alcohol dependence criteria were first met). RESULTS: Each method yielded subgroups that differed significantly from one another on demographic and clinical measures. Although concordance was high between the 2 age-of-onset methods, it was poor between the age-of-onset methods and the cluster analysis-derived approach. All 3 subtyping approaches significantly moderated the effects of sertraline or placebo, but only in the L'L' genotype group, as originally reported (Kranzler et al., 2011). In all cases, sertraline treatment was superior to placebo in later-onset individuals and inferior to placebo in the earlier-onset groups. CONCLUSIONS: Because age-of-onset subtypes can be defined retrospectively on an individual basis, they may be more clinically useful than cluster-derived subtypes, which require group data. Because the 2 age-of-onset measures we examined appear to have comparable validity, a single item is easier to use as a measure of the age of onset of problem drinking.
Drinking Days by Genotype and ClusterNumber of drinking days by Study Week, A/B Cluster Subtype, Medication Group, and 5-HTTLPR Genotype. Values are mean (±SEM) and reflect drinking behavior during the week identified on the x-axis. The decrease in drinking days from baseline to week 1 is not shown in the figure
Drinking Days by Genotype and Age of Onset of Problem DrinkingNumber of drinking days by Study Week, Age of Onset of Alcohol Dependence (based on a single item), Medication Group, and 5-HTTLPR Genotype. Values are mean (±SEM) and reflect drinking behavior during the week identified on the x-axis. The decrease in drinking days from baseline to week 1 is not shown in the figure
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Stress-response pathways are altered in the hippocampus of chronic alcoholics. | 2013 | 23981442 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Dopamine System in Mediating Alcohol Effects in Humans. | Beck A et al. | — | 2025 | → |
| Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. | Fischler PV et al. | — | 2022 | → |
| Exploring life-course patterns of substance abuse: a qualitative study. | Foster C et al. | — | 2021 | → |
| The neurobiology of addiction. | Uhl GR et al. | — | 2019 | → |
| Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men. | Isgro M et al. | — | 2017 | → |
| Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders. | Wilcox CE et al. | — | 2016 | → |
| Functional alterations in the dorsal raphe nucleus following acute and chronic ethanol exposure. | Lowery-Gionta EG et al. | — | 2015 | → |
| Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis. | Falk DE et al. | — | 2015 | → |
| Pharmacotherapy for alcohol dependence: A stratified approach. | Thompson A et al. | — | 2015 | → |
| Pharmacotherapy for alcohol use disorder: current and emerging therapies. | Swift RM et al. | — | 2015 | → |
| Serotonergic Systems in the Pathophysiology of Ethanol Dependence: Relevance to Clinical Alcoholism. | Marcinkiewcz CA | — | 2015 | → |
| Molecular basis of alcoholism. | Most D et al. | — | 2014 | → |
| Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings. | Kenna GA et al. | — | 2014 | → |
| Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study. | Kenna GA et al. | — | 2014 | → |
| Physical and mental health and social functioning in older alcohol-dependent inpatients: the role of age of onset. | van den Berg JF et al. | — | 2014 | → |
| Clinical practice. Alcohol use in adults. | Friedmann PD | — | 2013 | → |
| Stress-response pathways are altered in the hippocampus of chronic alcoholics. | McClintick JN et al. | — | 2013 | → |
| Commentary on comparison of alcoholism subtypes as moderators of the response to sertraline treatment. | Roache JD | — | 2012 | → |
| Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence. | Kranzler HR et al. | — | 2012 | → |